Noemi Nicosia

Ms. Noemi Nicosia

School of Medicine and Surgery, University of Milano-Bicocca, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NNNoemi Nicosia
Noemi Nicosia
MGMattia Giovenzana
Mattia Giovenzana
Paulina MisztakPaulina Misztak
Paulina Misztak
JMJessica Mingardi
Jessica Mingardi
LMLaura Musazzi
Laura Musazzi
Glutamate is the main excitatory neurotransmitter in the brain wherein it controls cognitive functional domains and mood. Indeed, brain areas involved in memory formation and consolidation as well as in fear and emotional processing, such as the hippocampus, prefrontal cortex, and amygdala, are predominantly glutamatergic. To ensure the physiological activity of the brain, glutamatergic transmission is finely tuned at synaptic sites. Disruption of the mechanisms responsible for glutamate homeostasis may result in the accumulation of excessive glutamate levels, which in turn leads to increased calcium levels, mitochondrial abnormalities, oxidative stress, and eventually cell atrophy and death. This condition is known as glutamate-induced excitotoxicity and is considered as a pathogenic mechanism in several diseases of the central nervous system, including neurodevelopmental, substance abuse, and psychiatric disorders. On the other hand, these disorders share neuroplasticity impairments in glutamatergic brain areas, which are accompanied by structural remodeling of glutamatergic neurons. In the current narrative review, we will summarize the role of glutamate-induced excitotoxicity in both the pathophysiology and therapeutic interventions of neurodevelopmental and adult mental diseases with a focus on autism spectrum disorders, substance abuse, and psychiatric disorders. Indeed, glutamatergic drugs are under preclinical and clinical development for the treatment of different mental diseases that share glutamatergic neuroplasticity dysfunctions. Although clinical evidence is still limited and more studies are required, the regulation of glutamate homeostasis is attracting attention as a potential crucial target for the control of brain diseases.

10 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Alessio AlesciAlessio Alesci
Alessio Alesci
NNNoemi Nicosia
Noemi Nicosia
AFAngelo Fumia
Angelo Fumia
FGFederica Giorgianni
Federica Giorgianni
Antonello SantiniAntonello Santini
Antonello Santini
Nicola CiceroNicola Cicero
Nicola Cicero
The use of polyphenols as adjuvants in lowering risk factors for various debilitating diseases has been investigated in recent years due to their possible antioxidant action. Polyphenols represent a fascinating and relatively new subject of research in nutraceuticals and nutrition, with interest rapidly expanding since they can help maintain health by controlling metabolism, weight, chronic diseases, and cell proliferation. Resveratrol is a phenolic compound found mostly in the pulp, peels, seeds, and stems of red grapes. It has a wide variety of biological actions that can be used to prevent the beginning of various diseases or manage their symptoms. Resveratrol can influence multiple inflammatory and non-inflammatory responses, protecting organs and tissues, thanks to its interaction with immune cells and its activity on SIRT1. This compound has anti-inflammatory, antioxidant, anti-apoptotic, neuroprotective, cardioprotective, anticancer, and antiviral properties, making it a potential adjunct to traditional pharmaceutical therapy in public health. This review aims to provide a comprehensive analysis of resveratrol in terms of active biological effects and mechanism of action in modifying the immune cellular response to promote human psychophysical health.

29 December 2021 in Natural Product Research
Verified
Journal Article
Closed access
AFAngelo Fumia
Angelo Fumia
Nicola CiceroNicola Cicero
Nicola Cicero
MGMarco Gitto
Marco Gitto
NNNoemi Nicosia
Noemi Nicosia
Alessio AlesciAlessio Alesci
Alessio Alesci
Neurodegeneration is a degenerative process characterized by the progressive loss of the structure and function of neurons that involves several immune cells. It is the primary cause of dementia and other several syndromes, known as neurodegenerative diseases. These disorders are age-related and it is estimated that by 2040 there will be approximately 81.1 million people suffering from these diseases. In addition to the traditional pharmacological therapy, in recent years nutraceuticals, naturally based compounds with a broad spectrum of biological effects: anti-aging, antioxidants, hypoglycaemic, hypocholesterolemic, anticancer, anxiolytic, antidepressant, etc., assumed an important role in counteracting these pathologies. In particular, several compounds such as astaxanthin, baicalein, glycyrrhizin, St. John's wort, and Ginkgo biloba L. extracts show particular neuroprotective and immunomodulatory abilities, involving several immune cells and some neurotransmitters that play a critical role in neurodegeneration, making them particularly useful in improving the symptoms and progression of neurodegenerative diseases. Graphical Abstract

13 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MKMagdalena Kotańska
Magdalena Kotańska
MKMonika Kubacka
Monika Kubacka
MBMarek Bednarski
Marek Bednarski
NNNoemi Nicosia
Noemi Nicosia
MSMałgorzata Szafarz
Małgorzata Szafarz
KKKatarzyna Kieć-Kononowicz
Katarzyna Kieć-Kononowicz
GPR18 is an orphan GPCR that is activated by the cannabinoid tetrahydrocannabinol (THC). Emerging evidence indicates its involvement in the control of cardiovascular functions, including heart rate, contractility, vascular tone, as well as blood pressure. Therefore, we investigated the effects of selective GPR18 receptor ligands, namely PSB-KD-107 (agonist) and PSB-CB-92 (antagonist), on blood pressure, electrocardiogram (ECG), and vascular dilatation in vitro and in vivo, as well as their anti-oxidative potential in in vitro ferric reducing antioxidant power (FRAP) and 2,2-diphenyl-1-picryl-hydrazyl-hydrate free radical (DPPH) assays. Our results clearly show that PSB-KD-107 dilates blood vessels. This effect is related to its activation of GPR18 as it can be blocked by the GPR18 antagonist PSB-CB-92. Moreover, our finding confirms the presence of GPR18 in blood vessels. The mechanism of the vasorelaxant activity of PSB-KD-107 is mainly related to endothelial nitric oxide generation; however, we cannot exclude additional nitric oxide-independent mechanisms or a direct influence on K+ channels. PSB-KD-107 may affect blood pressure and heart function after a single administration; however, this effect was no longer observed after repeated administrations once daily for eight days. PSB-KD-107 does not affect platelet aggregation—an important feature considering the safety of its administration. PSB-KD-107 also shows a significant anti-oxidant effect and further studies of its antioxidant activity in vivo are justified.

Verified
Journal Article
Open access
PDF file
HSHasan Shabbir
Hasan Shabbir
YCYanwen Chen
Yanwen Chen
JSjing sun
jing sun
MKMagdalena Kotańska
Magdalena Kotańska
NNNoemi Nicosia
Noemi Nicosia
Marek WojnickiMarek Wojnicki
Marek Wojnicki
Since their initial discovery in 2003, carbon quantum dots (CDs) have attracted significant attention due to their unique optical properties and potential biomedical applications. This review critically examines the past 20 years of research on CDs, with a particular focus on cytotoxicity studies from the last decade. CDs, typically less than 10 nm in size, have been synthesized from various organic and inorganic precursors using multiple methods, including hydrothermal, microwave, and chemical reduction techniques. Their properties can be finely tuned by modifying synthesis parameters and incorporating dopants. The preliminary studies on the biological effects of CDs were published in 2013, highlighting their antibacterial properties and low toxicity in certain contexts. Subsequent research has explored their bioactivity, including their application in drug delivery, bioimaging, and photothermal therapy. However, the cytotoxicity of CDs remains a critical area of investigation. Further studies have demonstrated that surface functional groups, charge, concentration, and size significantly influence their interaction with biological systems. For instance, CDs with positive surface charges exhibit higher cellular uptake and greater cytotoxicity compared to their negatively charged counterparts. In vivo studies utilizing animal models such as zebrafish, mice, and planarians have provided valuable insights into the potential toxicological impacts of CDs. The results indicate that while CDs generally exhibit low toxicity at certain concentrations, high doses can lead to adverse effects, including oxidative stress, organ damage, and disrupted cellular functions. Notably, the route of administration (oral, intravenous, or intraperitoneal) also affects the observed toxicity profiles. The goal of this review is to integrate the results of various studies to provide a balanced perspective on the potential risks and benefits of CDs, guiding future research and applications in nanomedicine. This review underscores the necessity for standardized and comprehensive toxicological evaluations of CDs to fully understand their safety and efficacy for biomedical applications.

20 December 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
MKMagdalena Kotańska
Magdalena Kotańska
KWKonrad Wojtaszek
Konrad Wojtaszek
MKMonika Kubacka
Monika Kubacka
MBMarek Bednarski
Marek Bednarski
NNNoemi Nicosia
Noemi Nicosia
Marek WojnickiMarek Wojnicki
Marek Wojnicki
Caramel, defined as a coloring agent and as an antioxidant, is used in several kinds of food products and is consumed by many people in different amounts. In our research we showed that the caramelization of sucrose under special conditions leads to the formation of carbon quantum dots (CQDs). So, it makes sense that humans also consume this type of CQDs, and it is theoretically possible for these particles to affect the body. Despite an increasing number of studies describing different types of CQDs, their biosafety is still not clearly understood. In our in vitro research, we examined the effects on platelet aggregation, protein glycation and lipid peroxidation of CQDs and caramel formed from a 20% sucrose solution. In vitro aggregation tests were conducted using freshly collected whole rat blood in a multiplate platelet function analyzer and measurer of electric impedance. The cytotoxic effect of the tested solutions on blood platelets was evaluated based on the release of lactate dehydrogenase. The formation of glycated bovine serum albumin was measured as fluorescence intensity and fructosamine level. The reducing power of the solutions was determined in adipose tissue, and their effect on lipid peroxidation in adipose tissue in vitro was also assessed. By measuring the intensity of hemolysis after incubation in solutions with red blood cell, we assessed their influence on the integration of the red blood cell membrane. All tests were performed in comparison with glucose and fructose and other frequently used sweeteners, such as erythritol and xylitol. Our study showed that caramel and CQDs formed from caramel may influence the glycation process and integrity of the red blood cell membrane, but unlike glucose and fructose, they decrease lipid peroxidation and may reduce Fe (III). Additionally, it is unlikely that they affect platelet aggregation. Compared to glucose and fructose, they may be safer for patients with metabolic disorders; however, further research is needed on the safety and biological activity of caramel and CQD.